CD40LG and systemic lupus erythematosus: ELISPOT has also been used to measure CD27+IgD+ B cells, the main B-1 and innate-like B cells, and IgM producers, using the PBMC from 50 SLE patient samples, revealing a decreased IgM-producing ability of CD27+IgD+ B cells [63].